Vitamin Shoppe Misses on the Top and Bottom Lines
Vitamin Shoppe (NYS: VSI) reported earnings on Feb. 26. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Dec. 29 (Q4), Vitamin Shoppe missed estimates on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue grew slightly. GAAP earnings per share didn't change.
Gross margins dropped, operating margins contracted, net margins were steady.
Vitamin Shoppe booked revenue of $218.9 million. The 12 analysts polled by S&P Capital IQ foresaw a top line of $223.9 million on the same basis. GAAP reported sales were the same as the prior-year quarter's.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.32. The 14 earnings estimates compiled by S&P Capital IQ predicted $0.40 per share. GAAP EPS of $0.32 were the same as the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 34.9%, much worse than the prior-year quarter. Operating margin was 7.5%, 130 basis points worse than the prior-year quarter. Net margin was 4.4%, much about the same as the prior-year quarter.
Next quarter's average estimate for revenue is $288.0 million. On the bottom line, the average EPS estimate is $0.72.
Next year's average estimate for revenue is $1.11 billion. The average EPS estimate is $2.42.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 43 members out of 53 rating the stock outperform, and 10 members rating it underperform. Among 25 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 17 give Vitamin Shoppe a green thumbs-up, and eight give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Vitamin Shoppe is outperform, with an average price target of $64.60.
Is Vitamin Shoppe the right retailer for your portfolio? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average retailing powerhouse. Click here for instant access to this free report.
- Add Vitamin Shoppe to My Watchlist.
The article Vitamin Shoppe Misses on the Top and Bottom Lines originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.